UZEDY is currently approved for use every one or two months as a subcutaneous long-acting injectable (LAI) for the treatment ...
ASX 200 futures are down 19pts (-0.23%) as of 8:30 am AEDT. In a nutshell: The S&P 500 is on a four day skid, down 3.0% ...